Latest News
January 1, Pfizer working on COVID-19 pill
Pfizer is working on a pill to combat COVID-19.
The company announced that its first participant entered the second trial phase of the three-phase study of its oral antiviral. The pill is intended to mitigate symptoms and hospitalizations.
The treatment is administered in 12-hour increments for five days to people who are symptomatic but not hospitalized. The trial will consist of 1,140 participants who will either receive the pill or a placebo.
If successful, Pfizer’s oral antiviral could help alleviate the strains on health care systems, as the treatment could help reduce the number of hospitalizations.
Source:
Could There Be a Daily COVID Pill? What We Know About Pfizer Drug Trial
-
Featured3 months agoBiden Abruptly Starts Yelling During Press Conference (Videos Inside)
-
Entertainment4 months agoWhoopi Goldberg’s “Wildly Inappropriate” Commentary Forces “The View” into Unscheduled Commercial Break
-
Featured3 months agoUS Advises Citizens to Leave This Country ASAP
-
Entertainment3 months agoLate Night Host is Getting Canceled After Staffers Speak Out
-
Featured3 months agoFox’s TV License Renewal At Risk Amid Unprecedented FCC Scrutiny
-
Featured3 months agoBenghazi Hero: Hillary Clinton is “One of the Most Disgusting Humans on Earth”
-
Featured3 months agoFox News Calls Security on Donald Trump Jr. at GOP Debate [Video]
-
Finance3 months agoTaxpayer Alert: Lawmakers Approve $750 Monthly Handouts